Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lungR T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports|May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancersR T Eagan, S Frytak, W C Nichols, et al.
Journal of Cellular Biochemistry|June 2, 2007
Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factorsJ R Hawse, M Subramaniam, J N Ingle, et al.
Surgery|April 1, 1986
Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancerC D Knight, J K Martin, J S Welch, et al.
Cancer Treatment Reports|September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lungR T Eagan, S Frytak, E T Creagan, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1995
Uranium dust exposure and lung cancer risk in four uranium processing operationsE A Dupree, J P Watkins, J N Ingle, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Cancer Research|November 21, 2000
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblastsG G Reinholz, B Getz, L Pederson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancerE T Creagan, S J Green, D L Ahmann, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lungR T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports|May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancersR T Eagan, S Frytak, W C Nichols, et al.
Journal of Cellular Biochemistry|June 2, 2007
Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factorsJ R Hawse, M Subramaniam, J N Ingle, et al.
Surgery|April 1, 1986
Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancerC D Knight, J K Martin, J S Welch, et al.
Cancer Treatment Reports|September 1, 1979
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lungR T Eagan, S Frytak, E T Creagan, et al.
Epidemiology (Cambridge, Mass.)|July 1, 1995
Uranium dust exposure and lung cancer risk in four uranium processing operationsE A Dupree, J P Watkins, J N Ingle, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Cancer Research|November 21, 2000
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblastsG G Reinholz, B Getz, L Pederson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancerE T Creagan, S J Green, D L Ahmann, et al.
Pageof 17